HUMAN PLATELET LYSATE MARKET ANALYSIS

Regional Analysis

Global Human Platelet Lysate Market - Regional Analysis

Among all regions, North America region is expected to dominate the market over the forecast period. This is attributed due to the increasing prevalence of chronic diseases such as Parkinson’s disease, osteoarthritis, androgenetic alopecia and others. For instance, according to data published on July 25, 2022, on National Institutes of Health (NIH), stated that in the U.S. approximately 500,000 people are diagnosed with Parkinson’s disease every year.

The Europe region is expected to second largest region over the forecast period. Due to increasing adoption of advanced blood collection & processing technology are expected to drive market growth over the forecast period. For instance, on May 31, 2022, Vitestro, a medical device company announced the launch of autonomous device for blood collection. The new device combines artificial intelligence (AI) and ultrasound-guided 3D reconstruction with robotic needle insertion to ensure the precise and secure collection of blood.

Figure 2. Global Human Platelet Lysate Market Share (%), by Region, 2023

Geographies covered:

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa